Global Cell Line Development Market to reach USD 11.51 billion by 2027.

Global Cell Line Development Market Size study, by Product (Equipment, Media, Reagents), Type (Primary Cell Lines, Continuous Cell Lines, Hybridomas, Recombinant Cell Lines) by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) and Regional Forecasts 2020-2027
Product Code:  HALDAT_59972285
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	Cell Line Development Market, by Region, 2018-2027 (USD Billion)
1.2.2.	Cell Line Development Market, by Product, 2018-2027 (USD Billion)
1.2.3.	Cell Line Development Market, by Type, 2018-2027 (USD Billion)
1.2.4.	Cell Line Development Market, by Application, 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Cell Line Development Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Cell Line Development Market Dynamics	
3.1.	Cell Line Development Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Cell Line Development Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Cell Line Development Market, by Product 
5.1.	Market Snapshot 
5.2.	Global Cell Line Development Market by Product, Performance - Potential Analysis
5.3.	Global Cell Line Development Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4.	Cell Line Development Market, Sub Segment Analysis
5.4.1.	 Equipment
5.4.2.	Media
5.4.3.	Reagents
Chapter 6.	Global Cell Line Development Market, by Type          
6.1.	Market Snapshot 
6.2.	Global Cell Line Development Market by Type, Performance - Potential Analysis
6.3.	Global Cell Line Development Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
6.4.	Cell Line Development Market, Sub Segment Analysis
6.4.1.	 Primary Cell Lines
6.4.2.	Continuous Cell Lines
6.4.3.	Hybridomas
6.4.4.	Recombinant Cell Lines
Chapter 7.	Global Cell Line Development Market, by Application 
7.1.	Market Snapshot 
7.2.	Global Cell Line Development Market by Application, Performance - Potential Analysis
7.3.	Global Cell Line Development Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
7.4.	Cell Line Development Market, Sub Segment Analysis
7.4.1.	 Bioproduction
7.4.2.	Tissue Engineering & Regenerative medicine
7.4.3.	Toxicity Testing
7.4.4.	Research
7.4.5.	Drug Discovery
Chapter 8.	Global Cell Line Development Market, Regional Analysis
8.1.	Cell Line Development Market, Regional Market Snapshot 
8.2.	North America Cell Line Development Market 
8.2.1.	U.S. Cell Line Development Market	 Product breakdown estimates & forecasts, 2017-2027	 Type breakdown estimates & forecasts, 2017-2027	 Application breakdown estimates & forecasts, 2017-2027 
8.2.2.	Canada Cell Line Development Market
8.3.	Europe Cell Line Development Market Snapshot
8.3.1.	U.K. Cell Line Development Market 
8.3.2.	Germany Cell Line Development Market
8.3.3.	France Cell Line Development Market
8.3.4.	Spain Cell Line Development Market
8.3.5.	Italy Cell Line Development Market
8.3.6.	Rest of Europe Cell Line Development Market
8.4.	Asia-Pacific Cell Line Development Market Snapshot
8.4.1.	China Cell Line Development Market 
8.4.2.	India Cell Line Development Market 
8.4.3.	Japan Cell Line Development Market
8.4.4.	Australia Cell Line Development Market
8.4.5.	South Korea Cell Line Development Market
8.4.6.	Rest of Asia Pacific Cell Line Development Market
8.5.	Latin America Cell Line Development Market Snapshot
8.5.1.	Brazil Cell Line Development Market
8.5.2.	Mexico Cell Line Development Market
8.6.	Rest of The World Cell Line Development Market

Chapter 9.	Competitive Intelligence
9.1.	Top Market Strategies
9.2.	Company Profiles
9.2.1.	 American Type Culture Collection (ATCC)	Key Information	Overview	Financial (Subject to Data Availability)	Product Summary	Recent Developments
9.2.2.	  Lonza Group AG
9.2.3.	Thermo Fisher Scientific Inc
9.2.4.	GE Healthcare
9.2.5.	Sigma-Aldrich Corporation
9.2.6.	Selexis SA
9.2.7.	European Collection of Cell Cultures (ECACC)
9.2.8.	Corning, Inc
9.2.9.	WuXi AppTec, Inc
9.2.10.	Sartorious AG
Chapter 10.	Research Process
10.1.	Research Process
10.1.1.	Data Mining
10.1.2.	Analysis
10.1.3.	Market Estimation
10.1.4.	Validation
10.1.5.	Publishing
10.2.	Research Attributes
10.3.	Research Assumption

Global Cell Line Development Market is valued approximately USD 4.21 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 13.40 % over the forecast period 2020-2027. The cell line is an established cell culture where the cell multiply in apt growth medium and space. The cell lines provide stepwise alternations in the physiology, structure and genetic makeup of the cells. Cell line development requires the discovery of single cell-derived clones that produce high and consistent levels of the target therapeutic protein. Cell lines are one of the chief tools used in research for studying the effects of drugs and toxic compounds on the cells , the biochemistry and normal physiology of cells, drug screening and development and large scale manufacturing of biological compounds. The application for cell lines includes research, bioproduction and diagnostics drives the market growth. Also, increasing demand for monoclonal antibodies and patent expiration of blockbuster biologics are expected to drive the cell line development industry over the forecast period. Further, increasing prevalence of autoimmune diseases and cancer is likely to increase the demand for accurate and cost-effective treatment options which is expected to render a positive impact on market growth. Moreover, rising vaccine production and growing demand for biosimilars foster the market growth. As in September 2020, Slentim launched a new workflow for single cell cloning of stem cells. the combination of Solentium’s VIPS instrument and new MatriClone Matrix demonstrates a 4 to 5- fold improvement in cloingcloning efficiency. While in the Same month, Octapharma announced to have selected Genedata’s Selector as its Central computational platform to streamline genomics- based cell line development and cell culture optimization workflow. However, High capital cost impedes the growth of the market over the forecast period of 2020-2027. Although, high investments in R&D presents a lucrative opportunity for the market.

The regional analysis of global Cell Line Development market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the large base of biopharmaceutical companies and research and academic institutes in the region along with swelling research programs. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rapidly improving health care facilities would create lucrative growth prospects for the Cell Line Development market across Asia-Pacific region.

Major market player included in this report are:
American Type Culture Collection (ATCC)
Lonza Group AG
Thermo Fisher Scientific Inc
GE Healthcare
Sigma-Aldrich Corporation
Selexis SA
European Collection of Cell Cultures (ECACC)
Corning, Inc
WuXi AppTec, Inc
Sartorious AG
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
By Type:
Primary Cell Lines
Continuous Cell Lines
Recombinant Cell Lines
By Application:
Tissue Engineering & Regenerative medicine
Toxicity Testing
Drug Discovery
By Region:
North America

Asia Pacific
South Korea
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Cell Line Development Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.